MAHMI database: a comprehensive MetaHit-based resource for the study of the mechanism of action of the human microbiota

The Mechanism of Action of the Human Microbiome (MAHMI) database is a unique resource that provides comprehensive information about the sequence of potential immunomodulatory and antiproliferative peptides encrypted in the proteins produced by the human gut microbiota. Currently, MAHMI database contains over 300 hundred million peptide entries, with detailed information about peptide sequence, sources and potential bioactivity. The reference peptide data section is curated manually by domain experts. The in silico peptide data section is populated automatically through the systematic processing of publicly available exoproteomes of the human microbiome. Bioactivity prediction is based on the global alignment of the automatically processed peptides with experimentally validated immunomodulatory and antiproliferative peptides, in the reference section. MAHMI provides researchers with a comparative tool for inspecting the potential immunomodulatory or antiproliferative bioactivity of new amino acidic sequences and identifying promising peptides to be further investigated. Moreover, researchers are welcome to submit new experimental evidence on peptide bioactivity, namely, empiric and structural data, as a proactive, expert means to keep the database updated and improve the implemented bioactivity prediction method. Bioactive peptides identified by MAHMI have a huge biotechnological potential, including the manipulation of aberrant immune responses and the design of new functional ingredients/foods based on the genetic sequences of the human microbiome. Hopefully, the resources provided by MAHMI will be useful to those researching gastrointestinal disorders of autoimmune and inflammatory nature, such as Inflammatory Bowel Diseases. MAHMI database is routinely updated and is available free of charge. Database URL: http://mahmi.org/

[1]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[2]  C. Yau,et al.  Immune recognition and response to the intestinal microbiome in type 1 diabetes. , 2016, Journal of autoimmunity.

[3]  K. Kataoka The intestinal microbiota and its role in human health and disease. , 2016, The journal of medical investigation : JMI.

[4]  J. Mclaughlin,et al.  Thyroid disorders and gastrointestinal and liver dysfunction: A state of the art review. , 2015, European journal of internal medicine.

[5]  L. Ruiz,et al.  Extracellular molecular effectors mediating probiotic attributes. , 2014, FEMS microbiology letters.

[6]  Hong-Jie Zhang,et al.  miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. , 2016, World journal of gastroenterology.

[7]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[8]  I. Korponay-Szabó,et al.  Adaptive diagnosis of coeliac disease. , 2015, Best practice & research. Clinical gastroenterology.

[9]  A. Margolles,et al.  Microbiota/Host Crosstalk Biomarkers: Regulatory Response of Human Intestinal Dendritic Cells Exposed to Lactobacillus Extracellular Encrypted Peptide , 2012, PloS one.

[10]  Gajendra P. S. Raghava,et al.  CancerPPD: a database of anticancer peptides and proteins , 2014, Nucleic Acids Res..

[11]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[12]  A. Sonnenberg,et al.  The stomach in health and disease , 2015, Gut.

[13]  Oliver Horlacher,et al.  MzJava: An open source library for mass spectrometry data processing. , 2015, Journal of proteomics.

[14]  A. Margolles,et al.  Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. , 2010, Microbiology.

[15]  D. Rubin,et al.  Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. , 2014, Journal of Crohn's & colitis.

[16]  A. Margolles,et al.  Lactobacillus plantarum Extracellular Chitin-Binding Protein and Its Role in the Interaction between Chitin, Caco-2 Cells, and Mucin , 2010, Applied and Environmental Microbiology.

[17]  S. Delgado,et al.  Molecular Players Involved in the Interaction Between Beneficial Bacteria and the Immune System , 2015, Front. Microbiol..

[18]  Gajendra P. S. Raghava,et al.  VaccineDA: Prediction, design and genome-wide screening of oligodeoxynucleotide-based vaccine adjuvants , 2015, Scientific Reports.

[19]  V. Tremaroli,et al.  Linking Microbiota to Human Diseases: A Systems Biology Perspective , 2015, Trends in Endocrinology & Metabolism.

[20]  J. Vanderleyden,et al.  Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens , 2010, Nature Reviews Microbiology.

[21]  H. Sales-Campos,et al.  Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[23]  Emily S. Charlson,et al.  Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications , 2011, Nature Biotechnology.

[24]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[25]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[26]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[27]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[28]  D. Haller,et al.  Dysbiosis in intestinal inflammation: Cause or consequence. , 2016, International journal of medical microbiology : IJMM.

[29]  Gérard Eberl,et al.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis , 2008, Nature.

[30]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[31]  M. Colonna,et al.  The multifaceted biology of plasmacytoid dendritic cells , 2015, Nature Reviews Immunology.

[32]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[33]  Janet K. Jansson,et al.  Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease , 2009, Inflammatory bowel diseases.

[34]  Sang-Uk Seo,et al.  Role of the gut microbiota in immunity and inflammatory disease , 2013, Nature Reviews Immunology.

[35]  G. Reid,et al.  Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases. , 2015, Inflammation & allergy drug targets.

[36]  R. Jewkes,et al.  Perceptions and Experiences of Research Participants on Gender-Based Violence Community Based Survey: Implications for Ethical Guidelines , 2012, PloS one.

[37]  E. Distrutti,et al.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. , 2016, World journal of gastroenterology.

[38]  P. Hornby Drug discovery approaches to irritable bowel syndrome , 2015, Expert opinion on drug discovery.

[39]  M. Bull,et al.  Part 1: The Human Gut Microbiome in Health and Disease. , 2014, Integrative medicine.

[40]  A. Hart,et al.  Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. , 2014, Molecular nutrition & food research.

[41]  H. Siljander,et al.  The role of the intestinal microbiota in type 1 diabetes mellitus , 2016, Nature Reviews Endocrinology.